Add time:09/03/2019         Source:sciencedirect.com

The aim of this study was to investigate the cutaneous penetration and metabolism of the new vitamin E prodrug δ-tocopherol glucoside (δ-TG), as compared to those of common vitamin E acetate, in vitro, both in reconstituted human epidermis and in viable human skin. Better diffusion was observed with α-tocopherol acetate (α-TAc) than with δ-tocopherol glucoside in both skin models, at 0.1% and 0.05% in a myritol solution; however, no metabolism was detected with α-tocopherol acetate. In all conditions tested (two skin models, two concentrations, three test times, and compartmental analysis) the δ-tocopherol glucoside was metabolized into free tocopherol. In the reconstituted human epidermis, after 18 h, over 90% of the δ-tocopherol glucoside was bioconverted. In the viable human skin, the extent of metabolism was about 20%, with 0.12 and 0.10 μg/cm2 of δ-tocopherol glucoside in the stratum corneum and epidermis, respectively. After topical application, the δ-tocopherol glucoside had a considerable reservoir effect, associated with gradual delivery of free tocopherol. The use of this gluco-conjugated vitamin E at a low concentration shows the capability of the skin to metabolize the prodrug in a slow and prolonged manner, making this gluco-conjugated vitamin E an excellent candidate for continuous reinforcement of antioxidants in the skin.

We also recommend Trading Suppliers and Manufacturers of δ-Tocopherol Acetate (cas 13027-26-4). Pls Click Website Link as below: cas 13027-26-4 suppliers